3-Chloro-4-(methylthio)phenylboronic acid, 98+%, 250mg

2-methyl-3,4-dihydropyrimidin-4-one, 98%, 25g

Methyl (R)-4-((3R,5R,7R,8R,9S,10S,13R,14S,17R)-3-((ethoxycarbonyl)oxy)-7-hydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate, 100mg

(2R,3R,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 96.0%, 25g

Glass vials with rolled rim, 35 ml, Height, 65 mm, 200 Piece(s)

Double neck round bottom flasks, 500 ml, 29/32, 29/32, 1 Piece

Imidazo[1,2-b]pyridazine-2-carboxylic acid, 97.0%, 5g

3,5-Difluorobenzamidoxime, 25g

7-amino-4-methyl-3,4-dihydro-1,4-benzoxazepin-5(2H)-one, 95.0%, 250mg

6,7-Dihydro-5H-pyrrolo[3,4-d]pyrimidine dihydrochloride, 95.0%, 500mg

(S,E)-1-(3-((1-methylpyrrolidin-2-yl)methyl)-5-(2-(phenylsulfonyl)vinyl)-1H-indol-1-yl)ethan-1-one, 98%, 50mg

3-Chloro-4,5-difluoro-benzoic acid, 95.0%, 25g

[(R)-(+)-2,2�-bis(diphenylphosphino)-1,1�-binaphthyl][(1S,2S)-(-)-1,2-diphenylethylenediamine]RuCl2, 95%, 1g